Actuate Therapeutics

ACTUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$19.389 M

$0.81 -11.01%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$22.2M

Loss-making

Shares outstanding

24,014,202

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#398Akari TherapeuticsAKTX$19.6M
#399Rocket OneRKTO$19.5M
#400Actuate TherapeuticsACTU$19.4M
#401Palatin TechnologiesPTN$18.3M
#402Jaguar HealthJAGX$17.9M

What if Actuate Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,259,004

Per share 1,559,331× higher

Bitcoin $1.74T

$72,526.04

Per share 89,827× higher

Nvidia $5.52T

$229,687.70

Per share 284,478× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Actuate Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.